MFS
ADMA icon

Mirabella Financial Services’s ADMA Biologics ADMA Stock Holding History

Mirabella Financial Services’s Portfolio ADMA Stock Details ADMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$159K Buy
+17,644
New +$278K 0.02% 809
2022
Q2 		– Sell
-101,510
Closed -$186K – 450
2022
Q1 		$186K Buy
+101,510
New +$158K 0.02% 408

Other funds holding ADMA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

Mirabella Financial Services's ADMA Position: Q1 2026 in Review

Mirabella Financial Services opened a new position in ADMA Biologics (ADMA) in Q1 2026: 17,644 shares worth $159K. The stake represents 0.02% of the portfolio and ranks #809 among its holdings. This is a return to the name: Mirabella Financial Services previously reported a position in ADMA as recently as Q1 2022.

Mirabella Financial Services first reported a position in ADMA in Q1 2022 and has held it in 2 quarters since. The position peaked at $186K in Q1 2022. 356 funds tracked by Wall St. Rank hold ADMA as of Q1 2026.

  • Mirabella Financial Services held 17,644 shares of ADMA Biologics worth $159K as of Q1 2026.
  • ADMA Biologics was a new Mirabella Financial Services position in Q1 2026.
  • ADMA Biologics made up 0.02% of Mirabella Financial Services's portfolio in Q1 2026, its #809 holding.
  • Mirabella Financial Services first reported a position in ADMA Biologics in Q1 2022 and has held it in 2 quarters since.
  • Mirabella Financial Services's ADMA Biologics position peaked at $186K in Q1 2022.
  • 356 funds tracked by Wall St. Rank held ADMA Biologics as of Q1 2026.

Based on Mirabella Financial Services's 13F filing for Q1 2026, filed 12 May 2026.